ASH 2018 Daily Wrap: MPN News

Published on

Topics include: Treatment and Understanding

Patient Power founders Andrew and Esther Schorr are joined by a panel of experts, including, Dr. Robyn M. Scherber, from the Mays Cancer Center at UT Health San Antonio MD Anderson, Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, and Dr. Larry Saltzman, from The Leukemia & Lymphoma Society (LLS),as they discuss research developments announced at the 2018 American Society of Hematology (ASH) meeting in San Diego. The panel shares clinical trial data, drug approvals and new therapies on the horizon with a focus on progress made in myeloproliferative neoplasms (MPN) and lymphomas. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring , , , and

Related Programs

What Treatments Are Available If Myelofibrosis Progresses to AML?

How many MPN patients go on to develop secondary AML? What medicines are offered to treat it? Dedicated researcher Dr. Naval Daver explains what percentage of myelofibrosis patients typically progress to AML, treatment options and patient response. Watch now to find out more.


Regulating the Course of MPNs: What Are Inhibitors and How Do They Work?

Can modern MPN treatments disrupt the abnormal molecular signaling in cancerous cells? A panel of MPN experts discuss pathway inhibitors and their effect on proliferative activity and disease course. Watch now to learn more.


An Expert’s Perspective on the Expanded Approval of Venetoclax

Dr. Susan O’Brien discusses the exciting new data propelling the recent approval for the expanded use of venetoclax and the impact it will have on those living with CLL.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on December 21, 2018